Metacrine, Inc.
Farnesoid X receptor agonists and uses thereof
Last updated:
Abstract:
Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
Status:
Grant
Type:
Utility
Filling date:
12 May 2020
Issue date:
4 Jan 2022